563 filings
Page 19 of 29
8-K
LRMR
Larimar Therapeutics Inc
7 Nov 17
Zafgen Reports Third Quarter 2017 Financial Results
12:00am
10-Q
2017 Q3
LRMR
Larimar Therapeutics Inc
Quarterly report
7 Nov 17
12:00am
4
Frances K Heller
17 Oct 17
ZAFGEN / Frances K Heller ownership change
12:00am
8-K
LRMR
Larimar Therapeutics Inc
12 Oct 17
Zafgen Appoints Jeffrey Hatfield as Chief Executive Officer; Thomas Hughes, Ph.D. to Continue as President, Appointed Chief Scientific Officer
12:00am
3
Hatfield Jeffrey S.
11 Oct 17
ZAFGEN / Jeffrey S. Hatfield ownership change
12:00am
4
Hatfield Jeffrey S.
11 Oct 17
ZAFGEN / Jeffrey S. Hatfield ownership change
12:00am
4
Hughes Thomas E.
11 Oct 17
ZAFGEN / Thomas E. Hughes ownership change
12:00am
EFFECT
LRMR
Larimar Therapeutics Inc
23 Aug 17
Notice of effectiveness
12:00am
CORRESP
LRMR
Larimar Therapeutics Inc
21 Aug 17
Correspondence with SEC
12:00am
UPLOAD
LRMR
Larimar Therapeutics Inc
14 Aug 17
Letter from SEC
12:00am
10-Q
2017 Q2
LRMR
Larimar Therapeutics Inc
Quarterly report
9 Aug 17
12:00am
S-3
LRMR
Larimar Therapeutics Inc
9 Aug 17
Shelf registration
12:00am
8-K
LRMR
Larimar Therapeutics Inc
8 Aug 17
Zafgen Reports Second Quarter 2017 Financial Results
12:00am
4
Dennis D Kim
12 Jul 17
ZAFGEN / DENNIS D KIM ownership change
12:00am
4
Perez Robert J
23 Jun 17
ZAFGEN / ROBERT J PEREZ ownership change
12:00am
4
Lamattina John L
23 Jun 17
ZAFGEN / JOHN L LAMATTINA ownership change
12:00am
4
Daniel Thomas O
23 Jun 17
ZAFGEN / Thomas O Daniel ownership change
12:00am
8-K
LRMR
Larimar Therapeutics Inc
23 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
4
Frances K Heller
23 Jun 17
ZAFGEN / Frances K Heller ownership change
12:00am
4
Booth Bruce
23 Jun 17
ZAFGEN / Bruce Booth ownership change
12:00am